TetraLogic Pharmaceuticals Corporation
TLOG
TLOG was delisted on the 3rd of November, 2016.
26 hedge funds and large institutions have $146K invested in TetraLogic Pharmaceuticals Corporation in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 0 closing their positions.
37% more funds holding
Funds holding: 19 → 26 (+7)
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
1.11% more ownership
Funds ownership: 2.68% → 3.78% (+1.1%)
29% less capital invested
Capital invested by funds: $205K → $146K (-$59K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$25.3K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$19K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$6.34K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5.69K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$3.69K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.02K |
| 2 |
Renaissance Technologies
New York
|
-$693 |
| 3 |
Bank of New York Mellon
New York
|
-$387 |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$106 |
TLOG Hedge Fund Activity: Q3 2016 in Review
26 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in TetraLogic Pharmaceuticals Corporation (TLOG) for Q3 2016, worth a combined $146K — down 29% from $205K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new TLOG positions and 0 closed out — a net gain of 7 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $25.3K. The largest seller was Morgan Stanley, cutting an estimated $1.02K.
- 26 institutional investors held TetraLogic Pharmaceuticals Corporation (TLOG) as of Q3 2016, up from 19 in Q2 2016.
- Funds reported $146K of TetraLogic Pharmaceuticals Corporation stock for Q3 2016, down 29% quarter-over-quarter.
- 7 funds opened new TetraLogic Pharmaceuticals Corporation positions in Q3 2016 and 0 closed out, a net change of +7 holders.
- The largest TetraLogic Pharmaceuticals Corporation buyer in Q3 2016 was Virtu KCG Holdings, an estimated $25.3K added.
- The largest TetraLogic Pharmaceuticals Corporation seller in Q3 2016 was Morgan Stanley, an estimated $1.02K sold.
Based on aggregated 13F filings for Q3 2016.